Mechanism and performance of choline-based ionic liquids in enhancing nasal delivery of glucagon
Journal of Controlled Release · 2024
DOI: 10.1016/j.jconrel.2024.09.035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2024. Verfasst von Zirong Dong und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Key Laboratory of Smart Drug Delivery of MOE, Fudan University, Shanghai 201203, China. Hauptthemen laut MEDLINE: Choline, Administration, Intranasal, Ionic Liquids, Glucagon. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Proteins and peptides have been increasingly developed as pharmaceuticals owing to their high potency and low side effects. However, their administration routes are confined to injections, such as intra-muscular and intra-venous injections, making patient compliance a challenge. Hence, non-injectable delivery systems are crucial to expanding the clinical use of proteins and peptides. In this context, two choline-based ionic liquids (ILs), namely, choline geranic acid ([Ch][Ger]) and choline citric acid ([Ch][Cit]), have been identified as promising agents for enhancing the permeation and prolonging the retention time of glucagon (GC) after intra-nasal administration. Notably, intra-nasal delivery of GC via ILs (GC/ILs) elicited rapid and smooth reversal of acute hypoglycaemia without leading to rebound hyperglycaemia in type 1 diabetic rats subjected to insulin induction. In addition, ILs could improve the transcellular transport of GC through electrostatic interaction. ILs could also transiently open inter-cellular tight junctions transiently to facilitate the paracellular transport of GC. Safety tests indicated that continuous intra-nasal delivery of ILs led to reversible changes, such as epithelial cell inflammation, goblet cell overgrowth, and impacts on the distribution of nasal cilia. However, these changes could be alleviated by the innate self-repair ability of mucosal epithelial cells. This study highlights the considerable potential of ILs for long-term nasal delivery of biomacromolecules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Key Laboratory of Smart Drug Delivery of MOE, Fudan University, Shanghai 201203, China.
- College of Chemical Engineering, North China University of Science and Technology, Tangshan 063210, PR China.
- School of Pharmacy, Key Laboratory of Smart Drug Delivery of MOE, Fudan University, Shanghai 201203, China. Electronic address: qijianping@fudan.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Dong, Z., Zhang, L., Li, G., Li, Y., He, H., Lu, Y., Wu, W., & Qi, J. (2024). Mechanism and performance of choline-based ionic liquids in enhancing nasal delivery of glucagon. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2024.09.035
Vancouver
Dong Z, Zhang L, Li G, Li Y, He H, Lu Y, et al. Mechanism and performance of choline-based ionic liquids in enhancing nasal delivery of glucagon. Journal of Controlled Release. 2024. doi:10.1016/j.jconrel.2024.09.035
BibTeX
@article{Dong2024,
author = {Dong, Zirong and Zhang, Luyu and Li, Guangyue and Li, Yang and He, Haisheng and Lu, Yi and Wu, Wei and Qi, Jianping},
title = {Mechanism and performance of choline-based ionic liquids in enhancing nasal delivery of glucagon},
journal = {Journal of Controlled Release},
year = {2024},
doi = {10.1016/j.jconrel.2024.09.035}
}
EUVIMED